Addyi was initial permitted from the FDA in August 2015 to deal with hypoactive sexual desire problem (HSDD) in premenopausal Women of all ages. That's just yet another way of saying it boosts sexual intercourse travel (also called libido) in Females which have not reached menopause. It was the very first this sort of drug accepted for this use.Une